See more : Kingsland Global Ltd. (KLO.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Delic Holdings Corp. (DELCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Delic Holdings Corp., a leading company in the Internet Content & Information industry within the Communication Services sector.
- Zynerba Pharmaceuticals, Inc. (ZYNE) Income Statement Analysis – Financial Results
- Glintt – Global Intelligent Technologies, S.A. (GLINT.LS) Income Statement Analysis – Financial Results
- Apollo Tyres Limited (APOLLOTYRE.NS) Income Statement Analysis – Financial Results
- Boyd Group Services Inc. (BYDGF) Income Statement Analysis – Financial Results
- The a2 Milk Company Limited (A2M.AX) Income Statement Analysis – Financial Results
Delic Holdings Corp. (DELCF)
Industry: Internet Content & Information
Sector: Communication Services
Website: https://deliccorp.com
About Delic Holdings Corp.
Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximately 10,000 pieces of content, including psychedelic guides, news, and culture; and Delic Radio, a podcast that discusses topics related to the psychedelic space with experts comprising discussions relating to news, science, culture, medicine, current affairs, and policy. The company also focuses on developing intellectual property through research and development for cannabis and psychedelics. In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.
Metric | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|
Revenue | 1.98M | 0.00 | 4.49M | 0.00 |
Cost of Revenue | 2.02M | 74.81K | 3.28M | 0.00 |
Gross Profit | -41.00K | -74.81K | 1.21M | 0.00 |
Gross Profit Ratio | -2.07% | 0.00% | 26.97% | 0.00% |
Research & Development | 214.00K | 46.11K | 0.00 | 0.00 |
General & Administrative | 5.19M | 732.10K | 137.24K | 41.11K |
Selling & Marketing | 1.94M | 232.62K | 144.29K | 0.00 |
SG&A | 7.13M | 964.73K | 137.24K | 41.11K |
Other Expenses | 0.00 | 39.96K | 0.00 | 0.00 |
Operating Expenses | 1.57M | 1.01M | 137.24K | 41.11K |
Cost & Expenses | 9.20M | 1.01M | 137.24K | 41.11K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 25.26 | 18.35 |
Depreciation & Amortization | 131.38K | 16.71K | 13.13K | 161.14K |
EBITDA | -5.75M | -489.47K | 467.56K | -41.11K |
EBITDA Ratio | -290.32% | 0.00% | -3.06% | 0.00% |
Operating Income | -7.22M | -383.85K | -137.24K | -41.11K |
Operating Income Ratio | -364.62% | 0.00% | -3.06% | 0.00% |
Total Other Income/Expenses | -2.27M | -423.58K | -377.98K | -18.35 |
Income Before Tax | -9.49M | -1.60M | -137.26K | -41.13K |
Income Before Tax Ratio | -479.19% | 0.00% | -3.06% | 0.00% |
Income Tax Expense | -628.00K | 420.69K | -0.77 | -161.14K |
Net Income | -8.86M | -1.60M | -137.26K | -41.13K |
Net Income Ratio | -447.48% | 0.00% | -3.06% | 0.00% |
EPS | -0.16 | -0.18 | 0.00 | 0.00 |
EPS Diluted | -0.16 | -0.18 | 0.00 | 0.00 |
Weighted Avg Shares Out | 54.75M | 9.11M | 37.67M | 38.12M |
Weighted Avg Shares Out (Dil) | 54.75M | 9.11M | 38.12M | 38.12M |
Delic Announces Ben Westhoff, Award-Winning Investigative Reporter Specializing in Fentanyl to Speak at Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Announces Ben Westhoff, Award-Winning Investigative Reporter Specializing in Fentanyl to Speak at Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Announces Laura Dawn, Msc., Host of the Psychedelic Leadership Podcast, Business Consultant & Microdosing Mentor to Appear at Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Announces Laura Dawn, Msc., Host of the Psychedelic Leadership Podcast, Business Consultant & Microdosing Mentor to Appear at Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Announces Aubrey Marcus, New York Times Best Selling Author and Founder/CEO of ONNIT to speak at Meet Delic: The World's Premiere Psychedelic and Wellness Event
DELIC Labs President and CSO Dr. Markus Roggen to Speak at MJBizCon
Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup
Leading Psychedelic Wellness Company Delic Completes Acquisition of Ketamine Infusion Centers LLC, Adding Health Clinic Chain to Portfolio
DELIC Labs Announces Partnership Agreement with Agilent Technologies
CBDV Rebrands as DELIC Labs, Cementing Its Place in the DELIC Ecosystem
Source: https://incomestatements.info
Category: Stock Reports